These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22079868)

  • 21. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
    Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
    Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference.
    Thakker DR; Natt F; Hüsken D; Maier R; Müller M; van der Putten H; Hoyer D; Cryan JF
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17270-5. PubMed ID: 15569935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-mediated delivery of siRNAs for anti-HIV therapy.
    Kim SS; Subramanya S; Peer D; Shimaoka M; Shankar P
    Methods Mol Biol; 2011; 721():339-53. PubMed ID: 21431696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Knockdown of cyclin A2 expression by small interfering RNA in MG-63 cells].
    Liu Y; Ding JY; Shen WL; Zhao X; Fan SW
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):670-5. PubMed ID: 18246796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of transfection conditions and analysis of siRNA potency using real-time PCR.
    Cheng A; Magdaleno S; Vlassov AV
    Methods Mol Biol; 2011; 764():199-213. PubMed ID: 21748642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
    Xiong XB; Uludağ H; Lavasanifar A
    Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of naked DNA uptake and expression.
    Wolff JA; Budker V
    Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing efficient siRNA knockdown in stem cells using fluorescent oligonucleotides.
    Chen SW; Oh SK
    Methods Mol Biol; 2010; 650():75-83. PubMed ID: 20686944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA interference as a tool for exploring HIV-1 robustness.
    Nevot M; Martrus G; Clotet B; Martínez MA
    J Mol Biol; 2011 Oct; 413(1):84-96. PubMed ID: 21875599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney.
    Hassan A; Tian Y; Zheng W; Ji H; Sandberg K; Verbalis JG
    Physiol Genomics; 2005 May; 21(3):382-8. PubMed ID: 15784697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression pattern of NuIP gene in adult mouse brain.
    Luo Y; Sarabi SA; Backman C; Shan L; Hoffer B; Federoff H
    Brain Res; 2009 Dec; 1302():42-53. PubMed ID: 19765553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals.
    Salahpour A; Medvedev IO; Beaulieu JM; Gainetdinov RR; Caron MG
    Biol Psychiatry; 2007 Jan; 61(1):65-9. PubMed ID: 16712807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
    Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
    Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. siRNA--getting the message out.
    Lee SH; Sinko PJ
    Eur J Pharm Sci; 2006 Apr; 27(5):401-10. PubMed ID: 16442784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.